KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $255.6 million.

  • Hims & Hers Health's Shares Outstanding (Diluted Average) rose 871.38% to $255.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $255.6 million, marking a year-over-year increase of 871.38%. This contributed to the annual value of $236.8 million for FY2024, which is 1311.91% up from last year.
  • Latest data reveals that Hims & Hers Health reported Shares Outstanding (Diluted Average) of $255.6 million as of Q3 2025, which was up 871.38% from $256.8 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Shares Outstanding (Diluted Average) ranged from a high of $256.8 million in Q2 2025 and a low of $153.1 million during Q1 2021
  • Over the past 5 years, Hims & Hers Health's median Shares Outstanding (Diluted Average) value was $208.4 million (recorded in 2023), while the average stood at $214.6 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 46167.63% in 2021, then soared by 219.26% in 2023.
  • Hims & Hers Health's Shares Outstanding (Diluted Average) (Quarter) stood at $186.8 million in 2021, then increased by 9.49% to $204.5 million in 2022, then grew by 2.36% to $209.3 million in 2023, then rose by 13.12% to $236.8 million in 2024, then rose by 7.92% to $255.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $255.6 million in Q3 2025, compared to $256.8 million in Q2 2025 and $246.6 million in Q1 2025.